Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Replimune Group Inc (REPL)

Replimune Group Inc (REPL)
8.71 -0.06 (-0.68%) 04/22/25 [NASDAQ]
8.70 x 64 8.71 x 13
Realtime by (Cboe BZX)
8.70 x 64 8.71 x 13
Realtime 8.71 unch (unch) 16:02 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
8.43
Day High
9.01
Open 8.86
Previous Close 8.77 8.77
Volume 1,216,830 1,216,830
Avg Vol 908,061 908,061
Stochastic %K 63.12% 63.12%
Weighted Alpha -25.12 -25.12
5-Day Change +1.13 (+15.05%) +1.13 (+15.05%)
52-Week Range 4.92 - 17.00 4.92 - 17.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 675,036
  • Shares Outstanding, K 77,015
  • Annual Sales, $ 0 K
  • Annual Income, $ -215,790 K
  • EBIT $ -241 M
  • EBITDA $ -251 M
  • 60-Month Beta 1.26
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.13

Options Overview Details

View History
  • Implied Volatility 108.22% ( -29.28%)
  • Historical Volatility 76.80%
  • IV Percentile 56%
  • IV Rank 25.67%
  • IV High 316.04% on 05/21/24
  • IV Low 36.44% on 10/01/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 11
  • Volume Avg (30-Day) 2,379
  • Put/Call OI Ratio 1.53
  • Today's Open Interest 41,743
  • Open Int (30-Day) 26,275

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.75
  • Number of Estimates 6
  • High Estimate -0.69
  • Low Estimate -0.80
  • Prior Year -0.82
  • Growth Rate Est. (year over year) +8.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.44 +34.16%
on 04/09/25
Period Open: 10.82
11.23 -23.06%
on 03/24/25
-2.18 (-20.15%)
since 03/21/25
3-Month
6.44 +34.16%
on 04/09/25
Period Open: 13.02
14.80 -41.60%
on 02/21/25
-4.38 (-33.64%)
since 01/22/25
52-Week
4.92 +75.61%
on 05/29/24
Period Open: 6.42
17.00 -49.18%
on 11/22/24
+2.22 (+34.58%)
since 04/22/24

Most Recent Stories

More News
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REPL : 8.71 (-0.63%)
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REPL : 8.71 (-0.63%)
Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

REPL : 8.71 (-0.63%)
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REPL : 8.71 (-0.63%)
Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma

REPL : 8.71 (-0.63%)
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REPL : 8.71 (-0.63%)
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials

REPL : 8.71 (-0.63%)
Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference

REPL : 8.71 (-0.63%)
Replimune Announces Pricing of Upsized Public Offering

REPL : 8.71 (-0.63%)
Replimune Group, Inc. Announces Proposed Public Offering of $125 Million in Common Stock and Pre-Funded Warrants

Replimune Group announced a proposed $125 million public stock offering, with an option for an additional $18.75 million.Quiver AI SummaryReplimune Group, Inc., a clinical stage biotechnology company specializing...

REPL : 8.71 (-0.63%)

Business Summary

Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United...

See More

Key Turning Points

3rd Resistance Point 10.95
2nd Resistance Point 10.14
1st Resistance Point 9.45
Last Price 8.71
1st Support Level 7.95
2nd Support Level 7.14
3rd Support Level 6.45

See More

52-Week High 17.00
Fibonacci 61.8% 12.39
Fibonacci 50% 10.96
Fibonacci 38.2% 9.53
Last Price 8.71
52-Week Low 4.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro